FDA Clears Diazyme Lipoprotein(a) Assay for Cardiovascular Risk Testing
The Food and Drug Administration (FDA) has granted 510(k) clearance for the Diazyme Lipoprotein(a) Molarity Assay, Diazyme Laboratories…
Otsuka’s kidney therapy gets accelerated FDA approval
Voyxact gets accelerated approval, offering investors a new entrant in the high-value kidney disease market. The Food and…
GEHC Stock Gains Following Launch of Revolution Vibe CT Imaging System
GE HealthCare GEHC recently announced that its innovative imaging solution, Revolution Vibe CT system, has received FDA 510(k) clearance.…
neurocare group’s Apollo TMS Therapy Devices Now Have FDA
Munich, Germany; Atlanta, Georgia – September 10, 2025 – neurocare group AG (“neurocare” or the “Company”), a leading…